DOCSLIB.ORG

Revised August 3, 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Revised August 3, 2017 Revised August 3, 2017 BIOGRAPHICAL SUMMARY George R. Pettit Birth: Long Branch, New Jersey Education: B.S., Chemistry, Washington State University, 1952. M.S., (Syn. and Heterocyclic Chem. with Prof. C. Djerassi), Wayne State University, 1954. Ph.D. (Structure and Steroid Chem. with Prof. C. Djerassi), Wayne State University, 1956. Positions: Teaching Assistant, Washington State University, 1950-52, Lecture Demonstrator, Washington State University, 1952. Research Chemist, E. I. DuPont deNemours and Co., Summer 1953. Graduate Teaching Assistant, Wayne State University, 1952-53. Research Fellow, Wayne State University, 1954-56. Senior Research Chemist, Norwich Eaton Pharmaceuticals, Inc.(now Procter and Gamble Co.), 1956-57. Assistant Professor of Chemistry, University of Maine, 1957-61. Associate Professor of Chemistry, University of Maine, 1961-65. Professor of Chemistry, University of Maine, 1965. Visiting Professor of Chemistry, Stanford University, 1965. Professor of Chemistry, Arizona State University, 1965 - present. Chairman, Organic Division, Arizona State University, 1966-68. Director, Cancer Research Laboratory, 1974-75. Director, Cancer Research Institute, 1975 -. Dalton Professor of Cancer Research and Medicinal Chemistry, 1986 -. Regents Professor of Chemistry, 1990 - present. Co-Director, Arizona Prostate Cancer Task Force, 2000-2010. Honors and Advisory Responsibilities Consultant: Smith-Kline-French Laboratories, 1959-1961. Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, 1965-1976. Special Study Sections, National Cancer Institute and National Institutes of Health, 1976- . Research Vice President and President Oregon State University, 2006 - 2011 Member: Editorial Board, Synthetic Communications, 1970- Journal of Natural Products, l984- 2011, Anti-Cancer Drug Design, 1990- , and Current Organic Chemistry, 1997-2010. Advisory Board, Walter Reed Medical Research Institute, 1985- 1990. The Amer. Inst. of Chemists Chemical Pioneer Award Selection Committee, 1989-97. Corresponding Member, European Organization for Research and Treatment of Cancer (EORTC), 1990- . Research Achievement Awards Committee, American Society of Pharmacognosy, 1996-99. Director, Scientific Advisory Council, International Cancer Advocacy Network (formerly IFADD) 1997- Reviewer, a number of research journals in organic chemistry and cancer, as well as for research grant applications. New York Academy of Sciences, Revised August 3, 2017 Past Member: Cancer Treatment Advisory Board, Division of Cancer Treatment, National Cancer Institute, 1971-1974. Medicinal Chemistry Fellowships Committee, National Institutes of Health, 1967-1970. American Chemical Society Awards Committee, 1968-1971, 1978-81, 1998-2002, 2012-. Washington State University Foundation Board, 1981-1985. Clinical Trials Board, U.K. Cancer Research Campaign 1985-2006 Fellow: American Institute of Chemists, 1970- . American Society of Pharmacognosy, 2007- Represented: Our government in negotiations for exchange of drugs for the treatment of cancer, March 17 - April 14, 1973. Part of the negotiations took place in Moscow, Riga, Leningrad, Kiev, and Yerevan, USSR. U.S. Academy of Sciences in a study of drug development and medicine in the People's Republic of China, June 1974. These responsibilities were performed in Peking, Shanghai, Tienstin, Nanching, Hanchow, and Kwangchow. The National Cancer Institute at a considerable number of university, research institute, and industrial laboratories from 1965. The University of Maine and Arizona State University as a lecturer at a large number of international scientific symposia, national scientific meetings, and at other universities from 1957. Memberships: American Chemical Society The Chemical Society (London) American Society of Clinical Oncology American Pharmacognosy Society American Association for Cancer Research National Academy of Inventors Phi Lambda Upsilon Honors: Washington State University Regents Distinguished Alumnus Award, 2012 Long Branch High Schools, Long Branch, New Jersey, Distinguished Alumni Academic Hall of Fame, 2009 Laverne Weber Visitng Scholar, Hatfield Marine Science Center, Oregon State University, 2009 Distinguished Lecture Series, School of Pharmacy, University of Pittsburgh, 2009 Special Issue of Journal of Natural Products dedicated to Professor G. Robert Pettit, March, 2008 Nolan & Gloria Sommer Award, Univ. of Nebraska, April 2000 Ernest Guenther Award in the Chemistry of Natural Products, American Chemical Society, 1998. Mathias P. Mertes Memorial Lecture Award, University of Kansas, Lawrence, Kansas 1997. Research Achievements Award, American Society of Pharmacognosy, 1995. State of Arizona Governor's Excellence Award, 1993. Regents Professor, Arizona State University, May 1990. Revised August 3, 2017 Outstanding Investigator Award - National Cancer Institute, 1989-2001. Chemical Pioneer Award, American Institute of Chemists, 1988. Appointed Dalton Professor of Medicinal Chemistry and Cancer Research, 1986. Alumni Achievement Award, Washington State University, 1983-1984. Distinguished Research Professorship, Arizona State University, Academic Year 1978-1979. Visiting Professor, South African Universities, Fall 1978. Presented named lecture series at a number of universities. Honorary Memberships: ARCS Foundation PAM Group European Organization for Research and Treatment of Cancer (EORTC). International Cancer Advocacy Network (formerly International Foundation for Anticancer Drug Discovery). Revised August 3, 2017 Publications: Books 1A. G. R. Pettit, SYNTHETIC PEPTIDES, Vol. 1, Van Nostrand Reinhold Co., New York, N.Y., 1970. 2A. G. R. Pettit, SYNTHETIC PEPTIDES, Vol. 2, Van Nostrand Reinhold Co., New York, N.Y., 1971. 3A. G. R. Pettit, SYNTHETIC PEPTIDES, Vol. 3, Academic Press, New York, N.Y., 1975. 4A. G. R. Pettit, SYNTHETIC PEPTIDES, Vol. 4, Elsevier Scientific Publishing Co., Amsterdam, The Netherlands, 1976. 5A. G. R. Pettit, SYNTHETIC PEPTIDES, Vol. 5, Elsevier Scientific Pub. Co., Amsterdam, The Netherlands, 1980. 6A. G. R. Pettit, SYNTHETIC PEPTIDES, Vol. 6, Elsevier Scientific Pub. Co., Amsterdam, The Netherlands, 1982. 7A. G. R. Pettit, SYNTHETIC NUCLEOTIDES, Vol. 1, Van Nostrand Reinhold Co., New York, N.Y., 1972. 8A. G. R. Pettit, BIOSYNTHETIC PRODUCTS FOR CANCER CHEMOTHERAPY, Vol. l, Plenum Publishing Co., New York, N.Y., 1977. 9A. G. R. Pettit and G. M. Cragg, BIOSYNTHETIC PRODUCTS FOR CANCER CHEMOTHERAPY, Vol. 2, Plenum Publishing Co., New York, N.Y., 1978. 10A. G. R. Pettit and R. H. Ode, BIOSYNTHETIC PRODUCTS FOR CANCER CHEMOTHERAPY, Vol. 3, Plenum Publishing Corp., New York, N.Y., 1979. 11A. G. R. Pettit, G. M. Cragg, and C. L. Herald, BIOSYNTHETIC PRODUCTS FOR CANCER CHEMOTHERAPY, Vol. 4, Elsevier Scientific Pub. Co., Amsterdam, 1984. 12A. G. R. Pettit, G. M. Cragg, and C. L. Herald, BIOSYNTHETIC PRODUCTS FOR CANCER CHEMOTHERAPY, Vol. 5, Elsevier Scientific Pub. Co., Amsterdam, 1985. 13A. G. R. Pettit, C. L. Herald, and C. R. Smith, BIOSYNTHETIC PRODUCTS FOR CANCER CHEMOTHERAPY, Vol. 6, Elsevier Scientific Pub. Co., Amsterdam, 1989. 14A. G. R. Pettit, F. Hogan-Pierson, C. L. Herald, ANTICANCER DRUGS FROM ANIMALS, PLANTS, AND MICROORGANISMS, John Wiley-Interscience, New York, 1993. Revised August 3, 2017 Chapters: 1B. G. R. Pettit and E. Van Tamelen, Desulfurization With Raney Nickel in "Organic Reactions," Vol. XII, Ed. by Arthur C. Cope, John Wiley and Sons, Inc., New York, 1962, Chapter 5, pp. 356-529. 2B. R. Ode, Y. Kamano, and G. R. Pettit, Cardenolides and Bufadienolides in "MTP International Review of Science, Organic Chemistry Series One," Vol. 8, Ed. by W. F. Johns, Butterworths, London, 1972, Chapter 6, pp. 151-177. 3B. R. Ode, G. R. Pettit, and Y. Kamano, Cardenolides and Bufadienolides in "International Review of Science, Organic Chemistry Series Two," Vol. 8, Ed. by W. F. Johns, Butterworths, London, 1975, Chapter 6, pp. 145-171. 4B. G. R. Pettit, C. R. Smith, and S. B. Singh, "Recent Advances in the Chemistry of Plant Antineoplastic Constituents," in Biologically Active Natural Products, Annual Proceedings of the Phytochemical Society of Europe, Clarendon Press, Oxford, Chap. 7, 1987, pp. 105-116. 5B. P. M. Blumberg, G. R. Pettit, B. S. Warren, A. Szallasi, L. D. Schuman, N. A. Sharkey, H. Nakakuma, M. L. Dell'Aquila, and D. J. de Vries, "The Protein Kinase C Pathway in Tumor Promotion," In: Skin Carcinogenesis: Mechanisms and Human Relevance, Alan R. Liss, Inc., N.Y., 1989, p. 201-212. 6B. G. R. Pettit, "The Bryostatins," in: Progress in the Chemistry of Organic Natural Products, No. 57, Founded by L. Zechmeister, Ed. by W. Herz, G. W. Kirby, W. Steglich, and Ch. Tamm, Springer-Verlag, New York, 1991, pp. 153-195. 7B. B. Gabrielsen, T. P. Monath, J. W. Huggins, J. J. Kirsi, M. Hollingshead, W. M. Shannon, and G. R. Pettit, “Activity of Selected Amaryllidaceae Constituents and Related Synthetic Substances Against Medically Important RNA Viruses,” in: Natural Products as Antiviral Agents, Ed. by C. K. Chu and H. G. Cutler, Plenum Press, New York, 1992, pp. 121-135. 8B. G. R. Pettit, "The Dolastatins," in Progress in the Chemistry of Organic Natural Products, Vol. 70, Ed. By W. Herz, G. W. Kirby, R. E. Moore, W. Steglich, and Ch. Tamm, Springer Verlag, New York, 1997, pp. 1-79. 9B. G. R. Pettit, C. L. Herald, and F. Hogan, “Biosynthetic Products for Anticancer Drug Design and Treatment: The Bryostatins,” in Anticancer Drug Development, ed. By B. Baguley, Academic Press, San Diego, CA, 2002, pp. 203-235. 10B. G. R. Pettit,
Load more

Recommended publications
  • Bufadienolides from the Skin Secretions of the Neotropical Toad Rhinella Alata (Anura: Bufonidae): Antiprotozoal Activity Against Trypanosoma Cruzi
    molecules Article Bufadienolides from the Skin Secretions of the Neotropical Toad Rhinella alata (Anura: Bufonidae): Antiprotozoal Activity against Trypanosoma cruzi Candelario Rodriguez 1,2,3 , Roberto Ibáñez 4 , Luis Mojica 5, Michelle Ng 6, Carmenza Spadafora 6 , Armando A. Durant-Archibold 1,3,* and Marcelino Gutiérrez 1,* 1 Centro de Biodiversidad y Descubrimiento de Drogas, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Apartado 0843-01103, Panama; [email protected] 2 Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur 522510, India 3 Departamento de Bioquímica, Facultad de Ciencias Naturales, Exactas y Tecnología, Universidad de Panamá, Apartado 0824-03366, Panama 4 Smithsonian Tropical Research Institute (STRI), Balboa, Ancon P.O. Box 0843-03092, Panama; [email protected] 5 Centro Nacional de Metrología de Panamá (CENAMEP AIP), Apartado 0843-01353, Panama; [email protected] 6 Centro de Biología Celular y Molecular de Enfermedades, INDICASAT AIP, Apartado 0843-01103, Panama; [email protected] (M.N.); [email protected] (C.S.) * Correspondence: [email protected] (A.A.D.-A.); [email protected] (M.G.) Abstract: Toads in the family Bufonidae contain bufadienolides in their venom, which are charac- Citation: Rodriguez, C.; Ibáñez, R.; terized by their chemical diversity and high pharmacological potential. American trypanosomiasis Mojica, L.; Ng, M.; Spadafora, C.; is a neglected disease that affects an estimated 8 million people in tropical and subtropical coun- Durant-Archibold, A.A.; Gutiérrez, M. tries. In this research, we investigated the chemical composition and antitrypanosomal activity Bufadienolides from the Skin of toad venom from Rhinella alata collected in Panama.
    [Show full text]
  • Bufo Viridis Secretions Improve Anxiety and Depression-Like Behavior Following Intracerebroventricular Injection of Amyloid Β
    Research in Pharmaceutical Sciences, December 2020; 15(6): 571-582 School of Pharmacy & Pharmaceutical Sciences Received: 12-07-2020 Isfahan University of Medical Sciences Peer Reviewed: 10-08-2020 Revised: 11-09-2020 Accepted: 14-11-2020 Published: 27-11-2020 Original Article Bufo viridis secretions improve anxiety and depression-like behavior following intracerebroventricular injection of amyloid β Shima Shirzad1, Ali Neamati1, *, Farzaneh Vafaee2,3, and Hamed Ghazavi2,3 1Department of Biology, Faculty of Science, Mashhad Branch, Islamic Azad University, Mashhad, I.R. Iran. 2Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, I.R. Iran. 3Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, I.R. Iran Abstract Background and purpose: Venenum Bufonis is a Chinese traditional medicine produced from the glandular secretions of toads that contain biogenic amines, which have anti-inflammatory properties. The present study aimed to examine the effect of Bufo viridis secretions (BVS) on anxiety and depression-like behavior and hippocampal senile plaques volume in an animal model of Alzheimer’s disease (AD). Experimental approach: Thirty-eight male Wistar rats were used. AD was induced by amyloid-beta (Aβ1-42) (10 µg/2 µL, intracerebroventricular injection, icv) and then BVS at 20, 40, and 80 mg/kg were injected intraperitoneally (ip) in six equal intervals over 21 days. Anxiety and depression-like behavior were assessed using behavioral tests including open field test (OFT), elevated plus maze (EPM), and forced swimming test (FST) 21 days after the surgery. The volume of senile plaques was assessed based on the Cavalieri principle. Findings/Results: Results of the OFT showed that the central crossing number and the time in the AD group were significantly decreased compared to the sham group (P ˂ 0.01 and P ˂ 0.001, respectively).
    [Show full text]
  • Archiv Für Naturgeschichte
    © Biodiversity Heritage Library, http://www.biodiversitylibrary.org/; www.zobodat.at Lepidoptera für 1903. Bearbeitet von Dr. Robert Lucas in Rixdorf bei Berlin. A. Publikationen (Autoren alphabetisch) mit Referaten. Adkin, Robert. Pyrameis cardui, Plusia gamma and Nemophila noc- tuella. The Entomologist, vol. 36. p. 274—276. Agassiz, G. Etüde sur la coloration des ailes des papillons. Lausanne, H. Vallotton u. Toso. 8 °. 31 p. von Aigner-Abafi, A. (1). Variabilität zweier Lepidopterenarten. Verhandlgn. zool.-bot. Ges. Wien, 53. Bd. p. 162—165. I. Argynnis Paphia L. ; IL Larentia bilineata L. — (2). Protoparce convolvuli. Entom. Zeitschr. Guben. 17. Jahrg. p. 22. — (3). Über Mimikry. Gaea. 39. Jhg. p. 166—170, 233—237. — (4). A mimicryröl. Rov. Lapok, vol. X, p. 28—34, 45—53 — (5). A Mimicry. Allat. Kozl. 1902, p. 117—126. — (6). (Über Mimikry). Allgem. Zeitschr. f. Entom. 7. Bd. (Schluß p. 405—409). Über Falterarten, welche auch gesondert von ihrer Umgebung, in ruhendem Zustande eine eigentümliche, das Auge täuschende Form annehmen (Lasiocampa quercifolia [dürres Blatt], Phalera bucephala [zerbrochenes Ästchen], Calocampa exoleta [Stück morschen Holzes]. — [Stabheuschrecke, Acanthoderus]. Raupen, die Meister der Mimikry sind. Nachahmung anderer Tiere. Die Mimik ist in vielen Fällen zwecklos. — Die wenn auch recht geistreichen Mimikry-Theorien sind doch vielleicht nur ein müßiges Spiel der Phantasie. Aitken u. Comber, E. A list of the butterflies of the Konkau. Journ. Bombay Soc. vol. XV. p. 42—55, Suppl. p. 356. Albisson, J. Notes biologiques pour servir ä l'histoire naturelle du Charaxes jasius. Bull. Soc. Etud. Sc. nat. Nimes. T. 30. p. 77—82. Annandale u. Robinson. Siehe unter S w i n h o e.
    [Show full text]
  • Chemistry, Spectroscopic Characteristics and Biological Activity of Natural Occurring Cardiac Glycosides
    IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB) ISSN: 2455-264X, Volume 2, Issue 6 Part: II (Sep. – Oct. 2016), PP 20-35 www.iosrjournals.org Chemistry, spectroscopic characteristics and biological activity of natural occurring cardiac glycosides Marzough Aziz DagerAlbalawi1* 1 Department of Chemistry, University college- Alwajh, University of Tabuk, Saudi Arabia Abstract:Cardiac glycosides are organic compounds containing two types namely Cardenolide and Bufadienolide. Cardiac glycosides are found in a diverse group of plants including Digitalis purpurea and Digitalis lanata (foxgloves), Nerium oleander (oleander),Thevetiaperuviana (yellow oleander), Convallariamajalis (lily of the valley), Urgineamaritima and Urgineaindica (squill), Strophanthusgratus (ouabain),Apocynumcannabinum (dogbane), and Cheiranthuscheiri (wallflower). In addition, the venom gland of cane toad (Bufomarinus) contains large quantities of a purported aphrodisiac substance that has resulted in cardiac glycoside poisoning.Therapeutic use of herbal cardiac glycosides continues to be a source of toxicity today. Recently, D.lanata was mistakenly substituted for plantain in herbal products marketed to cleanse the bowel; human toxicity resulted. Cardiac glycosides have been also found in Asian herbal products and have been a source of human toxicity.The most important use of Cardiac glycosides is its affects in treatment of cardiac failure and anticancer agent for several types of cancer. The therapeutic benefits of digitalis were first described by William Withering in 1785. Initially, digitalis was used to treat dropsy, which is an old term for edema. Subsequent investigations found that digitalis was most useful for edema that was caused by a weakened heart. Digitalis compounds have historically been used in the treatment of chronic heart failure owing to their cardiotonic effect.
    [Show full text]
  • Discovery and Characterization of a Prevalent Human Gut Bacterial Enzyme Sufficient for the Inactivation of a Family of Plant Toxins
    Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Koppel, Nitzan, Jordan E Bisanz, Maria-Eirini Pandelia, Peter J Turnbaugh, and Emily P Balskus. 2018. “Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins.” eLife 7 (1): e33953. doi:10.7554/eLife.33953. http://dx.doi.org/10.7554/ eLife.33953. Published Version doi:10.7554/eLife.33953 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:37160424 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA RESEARCH ARTICLE Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins Nitzan Koppel1, Jordan E Bisanz2, Maria-Eirini Pandelia3, Peter J Turnbaugh2,4*, Emily P Balskus1,5* 1Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States; 2Department of Microbiology & Immunology, University of California, San Francisco, United States; 3Department of Biochemistry, Brandeis University, Waltham, United States; 4Chan Zuckerberg Biohub, San Francisco, United States; 5Broad Institute, Cambridge, United States Abstract Although the human gut microbiome plays a prominent role in xenobiotic transformation, most of the genes and enzymes responsible for this metabolism are unknown.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,794,716 B2 Adair (45) Date of Patent: *Sep
    US007794,716 B2 (12) United States Patent (10) Patent No.: US 7,794,716 B2 Adair (45) Date of Patent: *Sep. 14, 2010 (54) ANTIBODY COMPOSITION AND PASSIVE Adair, C.D. et al. “Elevated Endoxin-Like Factor Complicating a MMUNIZATION AGAINST Multifetal Second Trimester Pregnancy: Treatment Digoxin-Binding PREGNANCY-INDUCED HYPERTENSION Immunoglobulin'. Am. J. Nephrol., 1996, vol. 16, pp. 529-531. Aizman, O. et al., “Ouabain, a steroid hormone that signals with slow (75) Inventor: Charles David Adair, Signal Mountain, calcium oscillations'. PNAS, 2001, vol.98, No. 23, pp. 13420-13424. TN (US) Amorium, M.M.R., et al., “Corticosteriod therapy for prevention of respiratory distress syndrome in severe preeclampsia'. Am. J. Obstet. (73) Assignee: Glenveigh Pharmaceuticals, LLC, Gyngol., 1999, vol. 180, No. 5, pp. 1283-1288. Chattanooga, TN (US) Bagrov, A. Y., et al., “Characterizatin of a Urinary Bufodienolide Na+, K+-ATPase Inhibitor in Patients. After Acute Myocardial Infarc (*) Notice: Subject to any disclaimer, the term of this tion'. Hypertension, 1998, vol. 31, pp. 1097-1 103. patent is extended or adjusted under 35 Ball, W. J. Jr. et al., “Isolation and Characterization of Human Monoclonal Antibodies to Digoxin'. The Journal of Immunology, U.S.C. 154(b) by 700 days. 1999, vol. 163, pp. 2291-2298. This patent is Subject to a terminal dis Butler, V. et al., “Digoxin-Specific Antibodies'. Proc. Natl. Acad. Sci. claimer. USA (Physiology), 1967, vol. 57, pp. 71-78. Dasgupta, A. et al., “Monitoring Free Digoxin Instead of Total Digoxin in Patients with Congestive Heart Failure and High Concen (21) Appl. No.: 11/317,378 trations of Dogoxin-like Immunoreactive Substances”.
    [Show full text]
  • Pharmaceutical Sciences
    JOURNAL OF Pharmaceutical Sciences December 1967 volume 56, number 12 ___ Review Article __ Pharmacology and Toxicology of Toad Venom By K. K. CHEN and ALENA KOVARiKOVA CONTENTS speare made the witch throw a toad into the hell-broth. It has been long believed that han- HISTORY.. 1535 dling of toads causes warts. In a small area of CHEMICALINGREDIEXTSOF TOADPOISOX. 1536 Pharmacology of Bufadienolides. 1536 the state of Illinois, folklore has 300 references Bufagins. .... 1536 to warts of toad origin, particularly their cures (2). Bufotoxins. ... .. .. 1538 These superstitions can of course be disproved Clinical Trials... .... 1539 by laboratory experience. Houssay (3) op- Catecholamines. .. .. 1539 Epinephrine.. .. .. .. 1539 erated on 15,000 toads for endocrine studies and Norephinephrine.. .. .. .. .. 1539 we handled more than 10,000 toads for the Indolealkylamines..... 1539 collection of their poisons-with no ill effects. Noncardiotonic Sterols. .. 1540 In form of a votive animal, the toad is associated Cholesterol. ... .. .. ... .. .. 1540 with the uterus and various gynecological dis- Provitamin D. .. .. 1540 -v-Sitosterol .......... ... .. .. 1540 eases (4) in Central Europe. Bronze toads of Miscellaneous Substances.. 1540 the Perm culture of Kortheastern Russia were USE OF THE VENOMTO THE TOAD. 1540 among the archaeological findings dating from Protection from Enemies. 1540 the middle of the 1st century A.D. Significance to Behavior. 1540 ="ATURALTOLERANCETO CARDIACGLYCO- Toad medicine has been advocated all over SIDESANDAGLYCONES. 1540 the world. For many years the Chinese have RESPONSEOFOTHERTISSUESTODRUGS. 1541 used a preparation of toad venom, ch'an su, REFERENCES. 1541 for the treatment of canker sores, toothache, HISTORY sinusitis, and local inflammations (5). During the 15th century a European physician wrote a FOR CENTURIES the toad has been known to book, "De Vcnenis," in which he mentioned that produce a poisonous secretion.
    [Show full text]
  • Systemic Delivery of the Anticancer Agent Arenobufagin Using Polymeric Nanomicelles
    Journal name: International Journal of Nanomedicine Article Designation: Original Research Year: 2017 Volume: 12 International Journal of Nanomedicine Dovepress Running head verso: Yuan et al Running head recto: Systemic delivery of arenobufagin open access to scientific and medical research DOI: http://dx.doi.org/10.2147/IJN.S139128 Open Access Full Text Article ORIGINAL RESEARCH Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles Xue Yuan1,2 Abstract: Arenobufagin (ABG) is a major active component of toad venom, a traditional Qian Xie1 Chinese medicine used for cancer therapy. However, poor aqueous solubility limits its Keyu Su1 pharmacological studies in vivo due to administration difficulties. In this study, we aimed to Zhijie Li3 develop a polymeric nanomicelle (PN) system to enhance the solubility of ABG for effective Dong Dong3 intravenous delivery. ABG-loaded PNs (ABG-PNs) were prepared with methoxy poly (ethylene Baojian Wu1,2 glycol)-block-poly (D,L-lactic-co-glycolic acid) (mPEG-PLGA) using the solvent-diffusion technique. The obtained ABG-PNs were 105 nm in size with a small polydispersity index of 1 Research Center for 0.08. The entrapment efficiency and drug loading were 71.9% and 4.58%, respectively. Cellular Biopharmaceutics and Pharmacokinetics, College of uptake of ABG-PNs was controlled by specific clathrin-mediated endocytosis. In addition, Pharmacy, 2Guangdong Province Key ABG-PNs showed improved drug pharmacokinetics with an increased area under the curve Laboratory of Pharmacodynamic value (a 1.73-fold increase) and a decreased elimination clearance (37.8% decrease). The Constituents of TCM and New Drugs Research, 3International Ocular nanomicelles showed increased drug concentrations in the liver and lung.
    [Show full text]
  • Of Dibang Valley, Mishmi Hills, Arunachal Pradesh, India
    JoTT NOTE 4(12): 3137–3160 Butterflies (Lepidoptera) of Dibang is protected under Mehao Wildlife Valley, Mishmi Hills, Arunachal Sanctuary (93030’–95045’N & Pradesh, India 28005’–28015’E) (MWS) (Image 1). Monsoon Jyoti Gogoi The Dibang River originates in the western part of China and flows through this valley in a north- Centre for Biodiversity and Natural Resource Conservation, Department of Ecology and Environmental Science, Assam south direction. It is one of the main tributaries of the University, Silchar, Assam 788011, India Brahmaputra. Email: [email protected] The vegetation is characterized by tropical evergreen forests (up to 900m), subtropical and The Mishmi Hills (95049’–95059’ N & 28006’– temperate forests (900–1800 m), temperate broad leaf 28023’E) are located in the eastern region of Arunachal forest (1800–2800 m) and temperate conifer forest Pradesh. The altitude varies from 400–3568 m. The (2800–3500 m) (Champion & Seth 1968). hill range lies to the north of the Assam Valley. The major part of the Mishmi Hills is in the Dibang Methods Valley districts of Arunachal Pradesh. The Dibang Study Area: 1. Sally Lake (Image 2): The Lake is Valley districts have two divisions - Lower and Upper about 5km from Roing Town and lies at an altitude of Dibang Valley. The headquarters of the two districts about 400m. The lake is very close to the Deopani are Roing and Anini, respectively. Roing lies on River and is surrounded by hills. Small streams flow the plains near the Lohit River while Anini is at an through the bamboo forest into the open areas.
    [Show full text]
  • Plant Ingestion: Foxglove Toxinology Scott Phillips
    Plant ingestion: foxglove toxinology Scott Phillips On our planet, there are over 1 million scientifically-named plants (only a third of which are assigned species names). And there are 7.5 billion potential consumers of these plants! Throughout the world, poisoning information centers report plant ingestion as a common exposure. In 2015, The American Association of Poison Control Centers (AAPCC) reported over 45,000 plant exposures. Counted among the top ten are cardiac glycosides (digitalis, convallarin, ouabain, oleandrin, bufadienolide, and more). Cardiac glycoside plants contain multiple and diverse glycosides. As early as the 16th century, scientists suspected Foxglove’s beneficial medical effects, although it wasn’t until January 1785 that Erasmus Darwin (Charles Darwin’s grandfather) submitted to the College of Physicians in London An Account of the Successful Use of Foxglove in Some Dropsies and in Pulmonary Consumption, and later that same year, Willian Withering published the classic text An Account of the Foxglove and some of its Medical Uses. According to anecdote, Withering substantiated his theory about the medical benefits of Foxglove after procuring a tea recipe from Mother Hutton, an herbalist physician from Shropshire, England, whose name and image pharmaceutical manufacturer Parke-Davis used nearly 150 years later in a marketing campaign. Regardless of the wellspring, Withering’s description of treating a patient with dropsy whose weak irregular pulse became regular and more forceful after receiving Foxglove started scientists down the path of using digitalis for the treatment of dropsy, Figure 1. Typical North kidney disease and other cardiac ailments. Despite American habitat of Foxglove use as a remedy for over 200 years, most recently digitalis preparations have fallen out of favor clinically because, even with adequate digitalization, heart rates did not differ between treated and untreated patients.
    [Show full text]
  • The Anticancer Effects of Cinobufagin on Hepatocellular Carcinoma Huh‑7 Cells Are Associated with Activation of the P73 Signaling Pathway
    MOLECULAR MEDICINE REPORTS 19: 4119-4128, 2019 The anticancer effects of cinobufagin on hepatocellular carcinoma Huh‑7 cells are associated with activation of the p73 signaling pathway LEI ZHAO1,2*, LINA FU3*, ZHONGWEI XU1, RONG FAN1, RUICHENG XU1, RONG FU1, SHUANG ZOU1, CONGCONG WANG1, YAN ZHANG1, JIABAO WANG1, JUN BAO1, ZHIMEI WANG1, XIAOJIE HOU1, YUPIAO ZHENG4, ERQING DAI2 and FENGMEI WANG4 1Central Laboratory, Logistics University of Chinese People's Armed Police Force, Tianjin 300309; 2Hepatology Department of Pingjin Hospital, Logistics University of Chinese People's Armed Police Forces, Tianjin 300162; 3Department of Gastroenterology, Tianjin Fourth Central Hospital, Tianjin 300140; 4Department of Gastroenterology and Hepatology, The Third Central Hospital of Tianjin, Tianjin 300170, P.R. China Received July 12, 2018; Accepted February 14, 2019 DOI: 10.3892/mmr.2019.10108 Abstract. The Na+/K+-ATPase inhibitor cinobufagin exhibits as well as the phosphorylation of p53 and mouse double minute numerous anticancer effects on hepatocellular carcinoma (HCC) 2 homolog, were significantly decreased in Huh‑7 cells treated cells expressing wild-type p53 via inhibition of aurora kinase A with 5 µmol/l cinobufagin for 24 h. Conversely, the expression (AURKA) and activation of p53 signaling. However, the effects of levels of Bcl-2-associated X protein, p21, p53 upregulated modu- cinobufagin on HCC cells expressing mutant p53 remain unclear. lator of apoptosis and phorbol-12-myristate-13-acetate-induced In the present study, the anticancer effects of cinobufagin were protein 1, were significantly increased by cinobufagin treat- investigated on HCC Huh-7 cells with mutant p53, and the effects ment. Overexpression or inhibition of AURKA suppressed or of AURKA overexpression or inhibition on the anticancer effects promoted the anticancer effects of cinobufagin on Huh-7 cells, of cinobufagin were analyzed.
    [Show full text]
  • Original Articles
    ORIGINAL ARTICLES NO~OUSTOADSANDFROGSOF all over the body, whereas granular glands are localised in special regions, such as the paratoid poison glands behind the SOUTH AFRICA head in toads. Because of their locality the paratoid glands, which do not secrete saliva, are often erroneously referred to as L Pantanowitz, TW aude, A Leisewitz 'parotid' glands. Granular glands produce a thicker, more toxic secretion. However, secretion from both mucous and granular glands may be poisonous.' While nearly all amphibians have a The major defence mechanism in frogs is via the secretion of trace of toxin in their skin: this is not equally developed in the toxins from their skin. In humans, intoxication may occur different genera. Both gland types are under the control of when part of the amphibian integument is ingested, as in the sympathetic nerves and discharge following a variety of l form of herbal medicines. Two groups of South African frogs stimuli. " Mucous glands secrete mainly when stimulated by have skin secretions that are potentially lethal to humans and dryness, whereas granular glands require pressure, injury or animals. Toad (BlIfo and Schismademla pecies), the any stress to the animal to cause secretion."'" With some amphibian with which man and his pets most frequently exceptions, notably BI/fv lIlaril/lIS (not a South African toad), have contact, secrete potent toxins with cardiac glycoside pre-metamorphic larvae lack toxic properties as granular activity. Topical and systemic intoxication, while seen in glands develop only at metamorphosis." humans, remains predominantly a veterinary problem. Amphibians are not equipped for speed, nor do they have Intoxication by the red-banded rubber frog, which secretes an any armament; as such they rely predominantly on chemical unidentified cardiotoxin, is far less common.
    [Show full text]